AADI BIOSCIENCE, INC. EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 7th, 2024 • Aadi Bioscience, Inc. • Pharmaceutical preparations • New Jersey
Contract Type FiledAugust 7th, 2024 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”) is entered into as of July 11, 2022 by and between Aadi Bioscience, Inc. (“Aadi”), and Bryan E. Ball (“Executive”). This Agreement will be effective August 15, 2022 (the “Effective Date”). As you know, Aadi recently consummated a merger (with the parent company of the merger being formerly known as Aerpio Pharmaceuticals, Inc. (“Aerpio”)) and Aerpio changed its name to Aadi Bioscience, Inc. as part of the merger. Aadi, together with any other subsidiaries, including the entity employing you, shall be referred to in this letter as the “Company”.
AADI BIOSCIENCE, INC. AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 29th, 2023 • Aadi Bioscience, Inc. • Pharmaceutical preparations • New Jersey
Contract Type FiledMarch 29th, 2023 Company Industry JurisdictionThis Amended and Restated Executive Employment Agreement (the “Agreement”) is entered into as of November 8, 2022 by and between Aadi Bioscience, Inc. (“Aadi”), and Brendan Delaney (“Executive”). This Agreement will be effective January 1, 2023 (the “Effective Date”) and amends and restates the Employment Agreement by and between the Executive and the Company, dated September 14, 2021 (the “Prior Agreement”). Aadi, together with any other subsidiaries, including the entity employing you, shall be referred to in this letter as the “Company”.
AADI BIOSCIENCE, INC. EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 10th, 2021 • Aadi Bioscience, Inc. • Pharmaceutical preparations • New Jersey
Contract Type FiledNovember 10th, 2021 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”) is entered into as of October 19, 2021 by and between Aadi Bioscience, Inc. (“Aadi”), and Loretta Itri, M.D. (“Executive”). This Agreement will be effective October 21, 2021 (the “Effective Date”). As you know, Aadi recently consummated a merger (with the parent company of the merger being formerly known as Aerpio Pharmaceuticals, Inc. (“Aerpio”)) and Aerpio changed its name to Aadi Bioscience, Inc. as part of the merger. Aadi, together with any other subsidiaries, including the entity employing you, shall be referred to in this letter as the “Company”.
PFENEX INC. EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • November 9th, 2016 • Pfenex Inc. • Pharmaceutical preparations • California
Contract Type FiledNovember 9th, 2016 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”) is entered into by and between Pfenex Inc. (the “Company”), and Steven S. Sandoval, Sr. (“Executive”). This Agreement will be effective as the date Executive commences employment with the Company (the “Effective Date”). It is expected that the Effective Date will be September 26, 2016.